US20060216320A1 - Composite of support matrix and collagen, and process for producing support substrate and composite - Google Patents

Composite of support matrix and collagen, and process for producing support substrate and composite Download PDF

Info

Publication number
US20060216320A1
US20060216320A1 US10/551,192 US55119205A US2006216320A1 US 20060216320 A1 US20060216320 A1 US 20060216320A1 US 55119205 A US55119205 A US 55119205A US 2006216320 A1 US2006216320 A1 US 2006216320A1
Authority
US
United States
Prior art keywords
cylindrical body
collagen
composite
fiber structure
bellows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/551,192
Other languages
English (en)
Inventor
Eiichi Kitazono
Takanori Miyoshi
Hiroaki Kaneko
Yoshihiko Sumi
Yukako Fukuhira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Assigned to TEIJIN LIMITED reassignment TEIJIN LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FUKUHIRA, YUKAKO, KANEKO, HIROAKI, KITAZONO, EIICHI, MIYOSHI, TAKANORI, SUMI, YOSHIHIKO
Publication of US20060216320A1 publication Critical patent/US20060216320A1/en
Priority to US13/031,934 priority Critical patent/US8263187B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable

Definitions

  • the present invention relates to a composite composed of collagen and a support matrix made of a fiber structure composed of aliphatic polyester fibers with a mean fiber size of 0.05-50 ⁇ m, to a cylindrical support matrix having a bellows-shaped section, and to a method for production of the support matrix and a method for production of the composite.
  • Recent years have seen an increase in active research in regenerative medicine, a technical field which takes advantage of the ability of cells to differentiate and proliferate to achieve reconstruction of original biological tissues and organs, as a method for treating major injury to or loss of biological tissue and organs.
  • Neural regeneration is a branch of this field, and research is underway toward using tubes composed of artificial materials for crosslinking between stumps in the neuron-deficient sites of patients with ablated neural tissue, to induce regeneration of the neural tissue.
  • Such tubes are made of silicon, polyurethane, polylactic acid, polyglycolic acid, polycaprolactone or their copolymers or composites, and they are often internally coated with collagen or laminin.
  • artificial material tubes made of polytetrafluoroethylene, polyester, polylactic acid, polyglycolic acid, polycaprolactone or their copolymers or composites, and these are also often internally coated with gelatin, albumin, collagen or laminin.
  • Japanese Unexamined Patent Publication HEI No. 6-285150 describes artificial vessels obtained by injecting insoluble collagen into the walls of cylindrical tubes made of a fibrous substance, and then subjecting them to chemical treatment before drying.
  • Japanese Unexamined Patent Publication HEI No. 7-148243 discloses an implant material whose matrix is a biocompatible bulky structure comprising organic fibers in a three-dimensional woven texture or knitted texture, or a composite texture obtained as a combination thereof, wherein the void fraction of the texture is preferably 20-90 vol %.
  • Japanese Unexamined Patent Publication HEI No. 8-294530 describes a cardiovascular restorative material characterized by insolubilizing a bioabsorbable substance attached to a porous matrix by at least one means having a physical effect of wet swelling by entanglement, heat treatment and charging.
  • Japanese Unexamined Patent Publication HEI No. 8-33661 describes an artificial vessel obtained by coacervation of water-soluble elastin and fixing with a crosslinking agent, either directly or after coating of gelatin or collagen and fixing with a crosslinking agent, onto the lumen surface of an artificial vessel matrix made of a synthetic resin.
  • Japanese Unexamined Patent Publication HEI No. 9-173361 describes an artificial vessel obtained by coating of albumin onto the lumen surface of an artificial vessel matrix made of a synthetic resin, and heating thereof or further crosslinking thereof with a crosslinking agent after the heating to construct an albumin layer, followed by coacervation of water-soluble elastin thereover and fixing with a crosslinking agent.
  • Japanese Unexamined Patent Publication No. 2003-126125 describes an artificial vessel having a cylindrical porous artificial vessel matrix, wherein the pores of the porous artificial vessel matrix are impregnated with a gel solution containing a biofunctional substance.
  • tubes having synthetic resins woven into a plain weave or knit as the matrix for an artificial vessel nonwoven fabric tubes formed from a synthetic resin shaped into a filament and roll laminated on a mandrel, or tubes obtained by extrusion molding of a mixture of a synthetic resin and a particulate aqueous solution of sodium chloride, but all of these methods yield artificial vessel matrix tubes which lack stretchability and have unsatisfactory Young's moduli.
  • Japanese Unexamined Patent Publication HEI No. 5-23362 discloses an artificial tube obtained by using multifilament yarn composed of polyester ultrafine filaments as the warp and weft yarns, and hollow weaving to yield a seamless tube which is then worked to form a bellows-shaped section.
  • Japanese Unexamined Patent Publication HEI No. 8-71093 discloses a modification whereby pleats are added to a conical fabric prosthetic vessel whose starting material is a fiber material.
  • the object is to provide such a matrix wherein the tube is a polymer compound having a bioabsorption property.
  • a composite comprising collagen and a support matrix made of a fiber structure composed of aliphatic polyester fibers with a mean fiber size of 0.05-50 ⁇ m.
  • a composite according to aspect 3 of the invention, wherein the aliphatic polyester is polylactic acid, polyglycolic acid, polycaprolactone or a copolymer thereof.
  • a composite according to aspect 5 of the invention wherein the cylindrical body is a cylindrical body which is composed of a fiber structure with a basis weight of 1-50 g/m 2 and has a membrane thickness of 0.05-0.2 mm and a diameter of 0.5-50 mm, wherein the spacing of the bellows-shaped section is no greater than 2 mm and the depth of the bellows-shaped section is 0.1-10 mm.
  • a cylindrical body characterized by being composed of a fiber structure with a basis weight of 1-50 g/m 2 and having a membrane thickness of 0.05-0.2 mm and a diameter of 0.5-50 mm, wherein the spacing of the bellows-shaped section is no greater than 2 mm and the depth of the bellows-shaped section is 0.1-10 mm.
  • a cylindrical body according to aspect 7 of the invention wherein the cylindrical body is a biodegradable polymer.
  • a cylindrical body according to aspect 9 of the invention, wherein the aliphatic polyester is polylactic acid, polyglycolic acid, polycaprolactone or a copolymer thereof.
  • a method for production of a composite composed of a cylindrical body and collagen wherein a composite is formed of a cylindrical body produced by a method according to aspect 12 of the invention, and collagen.
  • a method for production of a composite composed of a cylindrical body and collagen wherein a cylindrical body produced by a method according to aspect 12 of the invention is impregnated with a solution comprising collagen dissolved and/or dispersed in a solvent, and then at least one method is employed to fix the collagen by gelling, crosslinking or drying.
  • FIG. 1 is an example of an apparatus used in an electrostatic spinning method wherein the spinning solution is discharged into an electrostatic field, as a production method of the invention.
  • FIG. 2 is an example of an apparatus used in an electrostatic spinning method wherein fine droplets of the spinning solution are introduced into an electrostatic field, as a production method of the invention.
  • FIG. 3 is a cross-sectional view of a cylindrical body according to the invention.
  • the fiber structure used for the invention may be a three-dimensional structure formed by laminating and accumulating single or multiple filaments.
  • the form of the structure may be, for example, a nonwoven fabric, woven fabric, knitted fabric, mesh, yarn or the like.
  • the composite used for the invention is a composite composed of the aforementioned fiber structure and collagen.
  • the fiber structure used for the invention is made of an aliphatic polyester.
  • aliphatic polyesters there may be mentioned polylactic acid, polyglycolic acid, lactic acid-glycolic acid copolymer, polycaprolactone, polybutylene succinate, polyethylene succinate and their copolymers.
  • Preferred aliphatic polyesters among these are polylactic acid, polyglycolic acid, lactic acid-glycolic acid copolymer and polycaprolactone, with polylactic acid and polycaprolactone being particularly preferred.
  • the fiber structure used for the invention is preferably a cylindrical body with a bellows-shaped section.
  • the fiber structure of the invention has a basis weight of 1-50 g/m 2 , and is preferably not less than 1 g/m 2 because a structure will not be satisfactorily formed. It is also preferably not greater than 50 g/m 2 because the stretchability will be impaired when it is molded into a tube.
  • a more preferred basis weight range is 5-30 g/m 2
  • a particularly preferred basis weight range is 5-20 g/m 2 .
  • the membrane thickness of the fiber structure is preferably 0.05-0.2 mm, and more preferably 0.1-0.18 mm.
  • the fiber structure of the invention is a cylindrical body with a diameter of 0.5-50 mm, wherein the spacing of the bellows-shaped section is no greater than 2 mm and the depth of the bellows-shaped section is 0.1-10 mm, because if the spacing is greater than 2 mm, the stretchability will be impaired when it is molded into a tube.
  • the spacing of the bellows-shaped section is more preferably no greater than 1 mm.
  • the fiber structure of the invention is formed from fibers with a mean fiber size of 0.05-50 ⁇ m.
  • the mean fiber size is preferably not less than 0.05 ⁇ m because the strength of the fiber structure will not be maintained.
  • the mean fiber size is also preferably not greater than 50 ⁇ m because the stretchability may be reduced during molding into a tube, thus impairing the elastic modulus.
  • a more preferred range for the mean fiber size is 0.2-25 ⁇ m, and a particularly preferred range for the mean fiber size is 0.2-20 ⁇ m. The range is most preferably 0.3-10 ⁇ m.
  • the fiber size is the diameter of a fiber cross-section.
  • the mechanical properties of the fiber structure of the invention are preferably such that the Young's modulus is 1 ⁇ 10 2 -1 ⁇ 10 7 Pa and the yield elongation is 20% or greater.
  • a Young's modulus of less than 1 ⁇ 10 2 or greater than 2 ⁇ 10 7 , or a yield elongation of less than 20%, can lead to problems in terms of elasticity and stretchability, as well as compression and damage to regenerated neurons or vessels.
  • the method of producing the fiber structure of the invention may be an electrostatic spinning method, a spun bond method, a melt blow method, a flash spinning method or the like. Electrostatic spinning is preferred among these methods.
  • an electrostatic spinning method a solution of the aliphatic polyester in a volatile solvent is discharged into an electrostatic field formed between electrodes, and the solution is drawn toward the electrodes and the formed fiber substance is collected.
  • “Fibrous substance” includes not only one having the solvent of the solution already distilled off to form a fiber structure state, but also a substance still containing the solution solvent.
  • the electrodes used for the invention may be composed of any type of substance which exhibits conductivity, such as metal or an inorganic or organic substance.
  • the electrostatic field of the invention is formed between a pair of or more electrodes, and a high voltage may be applied to any of the electrodes. This includes, for example, cases using a total of three electrodes, i.e. two high-voltage electrodes with different voltage levels (for example, 15 kV and 10 kV) and an electrode which is grounded, as well as cases using more than three electrodes.
  • the concentration of the aliphatic polyester in the aliphatic polyester solution according to the invention is preferably 1-30 wt %.
  • the concentration of the aliphatic polyester is preferably not less than 1 wt % because such a low concentration will make it difficult to form a fiber structure. It is also preferably not greater than 30 wt % because the fiber size of the resulting fiber structure will be too large.
  • the concentration of the aliphatic polyester is more preferably 2-20 wt %.
  • methylene chloride chloroform
  • acetone methanol, ethanol, propanol
  • isopropanol toluene, tetrahydrofuran, 1,1,1,3,3,3-hexafluoroisopropanol
  • water 1,4-dioxane
  • carbon tetrachloride cyclohexane
  • cyclohexanone N,N-dimethylformamide and acetonitrile.
  • Particularly preferred among these are methylene chloride, chloroform and acetone, from the standpoint of solubility of the aliphatic polyester.
  • solvents may be used alone or in combinations of two or more. According to the invention, other solvents may also be used therewith so long as the object of the invention is not prevented.
  • any desired method may be used for discharge of the solution into the electrostatic field.
  • the solution 2 is supplied to a nozzle and situated at a suitable position in the electrostatic field, and the solution is drawn from the nozzle by the electric field to form a filament.
  • Any suitable apparatus may be used for this purpose, and for example, an injection needle-type solution ejection nozzle 1 having a voltage applied by appropriate means such as a high-voltage generator 6 , may be set at the tip end of the cylindrical solution holding tank 3 of an injector, and the solution directed to the tip.
  • the tip of the ejection nozzle 1 may be placed at an appropriate distance from a grounded fiber substance collecting electrode 5 , so that a fiber substance is formed between the tip and the fiber substance collecting electrode 5 when the solution 2 leaves the tip of the ejection nozzle 1 .
  • fine droplets of the solution may also be introduced into the electrostatic field by a self-evident method.
  • An example thereof will now be explained with reference to FIG. 2 .
  • the sole condition for this method is that the droplets must be held at a distance from the fiber substance collecting electrode 11 which allows fiber formation to occur in the electrostatic field.
  • an electrode 10 directly opposing the fiber substance collecting electrode 11 may be inserted directly into the solution 8 in the solution holding tank 9 comprising a nozzle 7 .
  • a plurality of nozzles may be used to increase the fiber substance production speed when the solution is supplied from the nozzle into the electrostatic field.
  • the distance between the electrodes will depend on the charge, the nozzle dimensions, the spinning solution flow rate and the spinning solution concentration, but a distance of 5-20 cm is appropriate for about 10 kV.
  • the electrostatic potential applied will generally be 3-100 kV, preferably 5-50 kV and more preferably 5-30 kV.
  • the desired potential may be created by any suitable method.
  • an electrode also serving as the collector, but a member serving as the collector may be situated between the electrodes as a collector separate from the electrodes.
  • the shape of the collector may be selected so as to yield a sheet or tube.
  • a belt-shaped material may be set between the electrodes as a collector to allow continuous production.
  • the solvent evaporates in response to the conditions while the solution is being drawn to the collector, thus forming a fiber substance.
  • the solvent will completely evaporate during the period until the substance is collected on the collector, but the drawing may be carried out under reduced pressure conditions if evaporation of the solvent is inadequate.
  • the temperature for drawing will depend on the evaporation behavior of the solvent and the viscosity of the spinning solution, but will ordinarily be 0-50° C. Accumulation of the fiber substance on the collector produces a fiber structure.
  • the method used for production of a cylindrical body composed of the fiber structure of the invention is not particularly restricted, but using a mandrel which has not been mirror surface-finished as the collector for electrostatic spinning is preferred since it will allow more convenient production of the cylindrical body. Specifically, by forming the fiber structure to a prescribed basis weight on the mandrel by electrostatic spinning and then removing the fiber structure from the mandrel while maintaining a suitable degree of friction, it is possible to conveniently obtain a cylindrical body having a bellows-shaped section.
  • the surface roughness of the mandrel is preferably 0.2-S or greater, and more preferably 1.5-400-S.
  • the fiber structure When the fiber structure is removed from the mandrel having a suitable surface roughness as described above, it is preferred to apply stress only to one end of the fiber structure.
  • the end of the fiber structure may be secured and the mandrel pulled out in the direction toward the secured end to apply stress only to that end.
  • the fiber structure is formed on the mandrel by electrostatic spinning, it is preferred to rotate the mandrel in the circumferential direction to form a more uniform cylindrical body.
  • the cylindrical body obtained according to the invention may be used alone, but it may also be used in combination with other members for reasons of handleability or other required performance.
  • the cylindrical body by combining the cylindrical body with an elastic body made of collagen or the like, it is possible to construct a member exhibiting optimal elasticity and strength.
  • the source of the collagen used for the invention is not particularly restricted, and it may be derived from any organism such as a mammal, bird, fish or the like. Collagen produced by cells such as bacteria, mold or yeast may also be used. Organism-derived collagen is preferably mammalian collagen, while collagen from cells such as bacteria, mold or yeast may be a recombinant form obtained by gene manipulation. There is also no particular restriction on the chemical structure of the collagen, which may be acid-solubilized collagen, neutral salt-solubilized collagen, enzyme-solubilized collagen, alkali-solubilized collagen or the like. Any desired amino acid sequences, such as telopeptides, of the collagen, as well as saccharides bonded to the collagen, may be removed depending on the purpose of use, and atelocollagen is preferred.
  • the soluble components extracted with aqueous acidic solutions or aqueous alkaline solutions are preferred for use.
  • the collagen obtained by extraction may be used directly in the form of an aqueous acidic solution or aqueous alkaline solution, but it is preferred to remove the excess low molecular ions by dialysis or ion exchange.
  • the means for forming the composite of the fiber structure and collagen according to the invention is preferably the following method.
  • a solution of the collagen dissolved and/or dispersed in an appropriate solvent is impregnated into the fiber structure and then fixed by at least one method such as gelling, crosslinking or drying, to form a collagen network.
  • the collagen dissolves in the solvent it may be utilized as a collagen solution, and if it does not dissolve in the solvent it may be utilized as a dispersion. Also, when a portion of the collagen dissolves or swells but does not completely dissolve, both the solution and dispersion may be utilized for the invention.
  • Any solvent may be selected, including water, amide-based solvents such as dimethylacetamide and sulfone-based solvents such as dimethylsulfoxide, but water is preferably used.
  • an inorganic salt such as calcium chloride or lithium chloride, a polyhydric alcohol such as glycerin or polyethylene glycol or a surfactant such as glycerin monostearate may be mixed into the solvent if necessary.
  • Gelling is a procedure whereby the collagen is gelled by heating under neutral conditions, and there are no particular restrictions on the reagent used for pH adjustment.
  • Crosslinking involves reacting the collagen with a compound having two or more functional groups which can react with collagen, and it is preferred to use a compound with a carbodiimide group or a compound with an active ester group.
  • the collagen concentration of the collagen solution, dispersion or semi-solution is preferably at least 0.1% and no greater than 10%. It is more preferably in the range of at least 0.2% and no greater than 8%.
  • the cylindrical body disclosed by the present invention may be lyophilized if necessary.
  • the conditions for lyophilization are not particularly restricted, but preferably the lyophilization temperature is no higher than ⁇ 5° C., and the vacuum degree during lyophilization is no greater than 100 MPa.
  • the collagen impregnated into the fiber structure may be a porous form depending on the purpose.
  • the method of forming pores is not particularly restricted, and sponge-like pores produced by lyophilization are also desirable for use.
  • the collagen may also contain particles which are soluble in organic solvents, and a method may be employed for their subsequent extraction with an organic solvent.
  • the fiber surfaces may also be coated with collagen for maximum utilization of the spaces of the fiber structure.
  • the composite obtained according to the invention may be used alone, but it may also be used in combination with other members for reasons of handleability or other required performance.
  • additives such as glycerin or polyethylene glycol may be included in order to increase the flexibility of the composite as a whole, or proteins such as growth factors and cytokines may also be added.
  • the end of the fiber structure collected at the fiber substance collecting electrode 5 was held fixed against a finger while the fiber substance collecting electrode 5 was pulled out toward the end fixed against the finger, to obtain a polylactic acid tube.
  • the obtained polylactic acid tube had a diameter of 2 mm, a length of 20 mm, a basis weight of 20 g/m 2 , a bellows-shaped section spacing of 0.5 mm and a bellows-shaped section depth of 0.1 mm.
  • the Young's modulus and yield elongation of the obtained molded article were measured using a Tensilon device (INSTRON) with reference to DIN53507, 53504. The results are shown in Table 1.
  • Example 2 The same treatment was carried out as in Example 1, except that the basis weight was 40 g/m 2 .
  • Example 2 The same treatment was carried out as in Example 1, except that the basis weight was 100 g/m 2 .
  • the collagen composite may be utilized as a vessel-substituting material such as an artificial vessel, or for regeneration of nerves or urinary ducts. It may also be employed as a cell culturing support in a test tube, or as an experimental material for cell evaluation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)
  • Laminated Bodies (AREA)
  • Prostheses (AREA)
US10/551,192 2003-03-31 2004-03-31 Composite of support matrix and collagen, and process for producing support substrate and composite Abandoned US20060216320A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/031,934 US8263187B2 (en) 2003-03-31 2011-02-22 Composite of support matrix and collagen, and method for production of support matrix and composite

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003094399 2003-03-31
JP2003-094399 2003-03-31
JP2003-383432 2003-11-13
JP2003383432 2003-11-13
PCT/JP2004/004620 WO2004087012A1 (ja) 2003-03-31 2004-03-31 支持基材とコラーゲンとの複合体、および支持基材と複合体の製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/031,934 Division US8263187B2 (en) 2003-03-31 2011-02-22 Composite of support matrix and collagen, and method for production of support matrix and composite

Publications (1)

Publication Number Publication Date
US20060216320A1 true US20060216320A1 (en) 2006-09-28

Family

ID=33134315

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/551,192 Abandoned US20060216320A1 (en) 2003-03-31 2004-03-31 Composite of support matrix and collagen, and process for producing support substrate and composite
US13/031,934 Expired - Fee Related US8263187B2 (en) 2003-03-31 2011-02-22 Composite of support matrix and collagen, and method for production of support matrix and composite

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/031,934 Expired - Fee Related US8263187B2 (en) 2003-03-31 2011-02-22 Composite of support matrix and collagen, and method for production of support matrix and composite

Country Status (8)

Country Link
US (2) US20060216320A1 (de)
EP (1) EP1618856B1 (de)
JP (1) JP4598671B2 (de)
KR (1) KR101075038B1 (de)
AT (1) ATE511816T1 (de)
AU (1) AU2004226561A1 (de)
CA (1) CA2520958C (de)
WO (1) WO2004087012A1 (de)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070224677A1 (en) * 2006-03-24 2007-09-27 Thomas Neumann Method for creating perfusable microvessel systems
US20090004239A1 (en) * 2007-06-27 2009-01-01 Sebastien Ladet Dural repair material
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
WO2009042418A1 (en) * 2007-09-24 2009-04-02 Nortis, Inc. Method for creating perfusable microvessel systems
US20100249811A1 (en) * 2007-12-07 2010-09-30 Toyo Boseki Kabushiki Kaisha Method for the manufacture of nerve regeneration-inducing tube
US20100279268A1 (en) * 2006-03-24 2010-11-04 Nortis, Inc. Method for creating perfusable microvessel systems
US9126366B2 (en) 2011-06-15 2015-09-08 Korea Institute Of Machinery & Materials Apparatus and method for manufacturing cell culture scaffold
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US9750837B2 (en) 2012-09-25 2017-09-05 Sofradim Production Haemostatic patch and method of preparation
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9867909B2 (en) 2011-09-30 2018-01-16 Sofradim Production Multilayer implants for delivery of therapeutic agents
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060089672A1 (en) * 2004-10-25 2006-04-27 Jonathan Martinek Yarns containing filaments made from shape memory alloys
EP1855618A2 (de) * 2005-03-07 2007-11-21 Georgia Tech Research Corporation Nanofilament-gerüst zur gewebewiederherstellung
JP4695430B2 (ja) * 2005-04-12 2011-06-08 帝人株式会社 円筒体および円筒体の製造方法
JP4864348B2 (ja) * 2005-05-27 2012-02-01 川澄化学工業株式会社 神経再生チューブ
JP2007215803A (ja) * 2006-02-17 2007-08-30 Teijin Ltd 円筒体
JP4988221B2 (ja) * 2006-02-22 2012-08-01 帝人株式会社 複合材料
JP4979264B2 (ja) * 2006-05-11 2012-07-18 兵庫県 密度勾配型不織布の製造方法
JP4904083B2 (ja) * 2006-05-17 2012-03-28 帝人株式会社 静電紡糸法により高分子化合物繊維構造体を製造する装置
JP5010854B2 (ja) * 2006-05-18 2012-08-29 帝人株式会社 血管再生材料
JP4982887B2 (ja) * 2007-02-20 2012-07-25 北海道曹達株式会社 神経再生チューブ及びその製造方法
CN101397367B (zh) * 2008-10-27 2011-06-08 中国科学院长春应用化学研究所 胶原分子片段接枝脂肪族聚酯二元或三元共聚物及制法和应用
EP2404622B1 (de) * 2009-02-02 2015-12-02 Toyobo Co., Ltd. Die nervenregeration induzierende röhre
JP5479584B2 (ja) * 2010-05-07 2014-04-23 帝人株式会社 生体糊用補強材及びその製造方法
KR101318393B1 (ko) * 2011-06-15 2013-10-15 한국기계연구원 세포배양지지체의 제조장치 및 세포배양지지체의 제조방법
JP6502857B2 (ja) 2013-01-14 2019-04-17 スクリップス ヘルス 組織アレイプリンティング
JP6188514B2 (ja) * 2013-09-25 2017-08-30 テルモ株式会社 蛇腹状管腔構造体
WO2015138970A1 (en) 2014-03-14 2015-09-17 Scripps Health Electrospinning of cartilage and meniscus matrix polymers
KR101644828B1 (ko) * 2014-04-21 2016-08-02 한림대학교 산학협력단 조직 재생용 3차원 구조체의 제조 방법, 제조 장치 및 이에 따른 구조체
CN103993425A (zh) * 2014-06-13 2014-08-20 东华大学 一种聚己内酯-角蛋白复合纳米纤维膜的制备方法
CZ308556B6 (cs) * 2017-07-26 2020-11-25 Vseobecna Fakultni Nemocnice V Praze Kompozitní cévní náhrada a způsob její výroby
JP6423054B2 (ja) * 2017-08-01 2018-11-14 テルモ株式会社 蛇腹状管腔構造体
CN116650342A (zh) * 2019-10-30 2023-08-29 诺斯贝尔化妆品股份有限公司 酵母重组胶原蛋白的胶原纳米速溶面膜及制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463158A (en) * 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
US5298276A (en) * 1990-08-24 1994-03-29 Swaminathan Jayaraman Process for producing artificial blood vessels of controlled permeability and product produced thereby
US5697970A (en) * 1994-08-02 1997-12-16 Meadox Medicals, Inc. Thinly woven flexible graft
US6090117A (en) * 1996-11-20 2000-07-18 Yasuhiko Shimizu Artificial neural canal
US6576019B1 (en) * 1997-10-31 2003-06-10 Children's Medical Center Corporation Bladder reconstruction

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337673A (en) * 1958-07-31 1967-08-22 Us Catheter & Instr Corp Uniformly corrugated prosthesis and process of making same
US3588920A (en) * 1969-09-05 1971-06-29 Sigmund A Wesolowski Surgical vascular prostheses formed of polyester fiber paper
GB1577221A (en) * 1976-02-04 1980-10-22 Ici Ltd Vascular prosthesis
JPS6145766A (ja) * 1984-08-07 1986-03-05 宇部興産株式会社 人工血管
JPH0675594B2 (ja) * 1986-02-12 1994-09-28 鐘紡株式会社 人工血管の製造方法
US5236447A (en) * 1990-06-29 1993-08-17 Nissho Corporation Artificial tubular organ
JPH0523362A (ja) 1991-07-22 1993-02-02 Atsusato Kitamura 人工血管の製造法
JP3335668B2 (ja) * 1992-06-12 2002-10-21 テルモ株式会社 人工血管
JPH06285150A (ja) 1993-04-02 1994-10-11 Koken Co Ltd 人工血管
CA2149900C (en) 1993-09-24 2003-06-24 Yasuo Shikinami Implant material
JP3687995B2 (ja) 1994-07-22 2005-08-24 住友ベークライト株式会社 人工血管及びその製造方法
DE4430485C1 (de) 1994-08-27 1996-03-07 Braun B Surgical Gmbh Textile Gefäßprothese, Verfahren zu ihrer Herstellung und Werkzeug zu ihrer Herstellung
JP3799626B2 (ja) 1995-04-25 2006-07-19 有限会社ナイセム 心臓血管修復材及びその製造方法
WO1996036297A1 (fr) * 1995-05-19 1996-11-21 Kanji Inoue Instrument de transplantation, procede pour le courber et procede pour le transplanter
JP3573554B2 (ja) 1995-12-27 2004-10-06 住友ベークライト株式会社 人工血管及びその製造方法
CA2273832A1 (en) * 1996-12-06 1998-06-11 Tapic International Co., Ltd. Artificial blood vessel
JPH10277068A (ja) * 1997-04-08 1998-10-20 Ube Ind Ltd ステント付き人工血管
US20020090725A1 (en) * 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
JP3686833B2 (ja) * 2000-11-28 2005-08-24 壮介 木村 血管吻合用リング及び血管吻合用リングを装着した人工血管
JP2003126125A (ja) 2001-10-24 2003-05-07 Katsuko Sakai 人工血管及びその製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463158A (en) * 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
US5298276A (en) * 1990-08-24 1994-03-29 Swaminathan Jayaraman Process for producing artificial blood vessels of controlled permeability and product produced thereby
US5697970A (en) * 1994-08-02 1997-12-16 Meadox Medicals, Inc. Thinly woven flexible graft
US6090117A (en) * 1996-11-20 2000-07-18 Yasuhiko Shimizu Artificial neural canal
US6576019B1 (en) * 1997-10-31 2003-06-10 Children's Medical Center Corporation Bladder reconstruction

Cited By (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8846307B2 (en) 2006-03-24 2014-09-30 Nortis, Inc. Method for creating perfusable microvessel systems
US20070224677A1 (en) * 2006-03-24 2007-09-27 Thomas Neumann Method for creating perfusable microvessel systems
US9446169B2 (en) 2006-03-24 2016-09-20 Nortis, Inc. Method for creating perfusable microvessel systems
US7622298B2 (en) 2006-03-24 2009-11-24 Norits, Inc. Method for creating perfusable microvessel systems
US20090317787A1 (en) * 2006-03-24 2009-12-24 Nortis, Inc. Method for creating perfusable microvessel systems
US20100279268A1 (en) * 2006-03-24 2010-11-04 Nortis, Inc. Method for creating perfusable microvessel systems
US8003388B2 (en) 2006-03-24 2011-08-23 Nortis, Inc. Method for creating perfusable microvessel systems
US8445280B2 (en) 2006-03-24 2013-05-21 Nortis, Inc. Method for creating perfusable microvessel systems
US20090004239A1 (en) * 2007-06-27 2009-01-01 Sebastien Ladet Dural repair material
US8932619B2 (en) 2007-06-27 2015-01-13 Sofradim Production Dural repair material
US9750846B2 (en) 2007-09-07 2017-09-05 Sofradim Production Sas Bioresorbable and biocompatible compounds for surgical use
US20090068250A1 (en) * 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
WO2009042418A1 (en) * 2007-09-24 2009-04-02 Nortis, Inc. Method for creating perfusable microvessel systems
US10368971B2 (en) 2007-12-03 2019-08-06 Sofradim Production Implant for parastomal hernia
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US8632844B2 (en) 2007-12-07 2014-01-21 Toyo Boseki Kabushiki Kaisha Method for the manufacture of nerve regeneration-inducing tube
US20100249811A1 (en) * 2007-12-07 2010-09-30 Toyo Boseki Kabushiki Kaisha Method for the manufacture of nerve regeneration-inducing tube
US9687592B2 (en) 2007-12-07 2017-06-27 Toyo Boseki Kabushiki Kaisha Method for the manufacture of nerve regeneration-inducing tube
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US10070948B2 (en) 2008-06-27 2018-09-11 Sofradim Production Biosynthetic implant for soft tissue repair
US11970798B2 (en) 2009-09-04 2024-04-30 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US10472750B2 (en) 2011-03-16 2019-11-12 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US11612472B2 (en) 2011-03-16 2023-03-28 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9126366B2 (en) 2011-06-15 2015-09-08 Korea Institute Of Machinery & Materials Apparatus and method for manufacturing cell culture scaffold
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US11039912B2 (en) 2011-07-13 2021-06-22 Sofradim Production Umbilical hernia prosthesis
US10709538B2 (en) 2011-07-13 2020-07-14 Sofradim Production Umbilical hernia prosthesis
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US11903807B2 (en) 2011-07-13 2024-02-20 Sofradim Production Umbilical hernia prosthesis
US9867909B2 (en) 2011-09-30 2018-01-16 Sofradim Production Multilayer implants for delivery of therapeutic agents
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US11266489B2 (en) 2011-12-29 2022-03-08 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US11925543B2 (en) 2011-12-29 2024-03-12 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10342652B2 (en) 2011-12-29 2019-07-09 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US11471256B2 (en) 2011-12-29 2022-10-18 Sofradim Production Prosthesis for inguinal hernia
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US9750837B2 (en) 2012-09-25 2017-09-05 Sofradim Production Haemostatic patch and method of preparation
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US11622845B2 (en) 2013-06-07 2023-04-11 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US11304790B2 (en) 2013-06-07 2022-04-19 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US11291536B2 (en) 2014-09-29 2022-04-05 Sofradim Production Whale concept-folding mesh for TIPP procedure for inguinal hernia
US10653508B2 (en) 2014-09-29 2020-05-19 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US11589974B2 (en) 2014-09-29 2023-02-28 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US11713526B2 (en) 2014-12-05 2023-08-01 Sofradim Production Prosthetic porous knit
US10745835B2 (en) 2014-12-05 2020-08-18 Sofradim Production Prosthetic porous knit
US11359313B2 (en) 2014-12-05 2022-06-14 Sofradim Production Prosthetic porous knit
US10815345B2 (en) 2015-02-17 2020-10-27 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US11439498B2 (en) 2015-04-24 2022-09-13 Sofradim Production Prosthesis for supporting a breast structure
US10660741B2 (en) 2015-04-24 2020-05-26 Sofradim Production Prosthesis for supporting a breast structure
US11826242B2 (en) 2015-06-19 2023-11-28 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US11389282B2 (en) 2016-01-25 2022-07-19 Sofradim Production Prosthesis for hernia repair
US11696819B2 (en) 2016-10-21 2023-07-11 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US11672636B2 (en) 2017-05-02 2023-06-13 Sofradim Production Prosthesis for inguinal hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair

Also Published As

Publication number Publication date
JP4598671B2 (ja) 2010-12-15
KR20050120687A (ko) 2005-12-22
EP1618856A1 (de) 2006-01-25
CA2520958A1 (en) 2004-10-14
CA2520958C (en) 2011-08-09
US20110140312A1 (en) 2011-06-16
ATE511816T1 (de) 2011-06-15
AU2004226561A1 (en) 2004-10-14
US8263187B2 (en) 2012-09-11
EP1618856B1 (de) 2011-06-08
EP1618856A4 (de) 2008-04-02
JPWO2004087012A1 (ja) 2006-06-29
WO2004087012A1 (ja) 2004-10-14
KR101075038B1 (ko) 2011-10-19

Similar Documents

Publication Publication Date Title
US8263187B2 (en) Composite of support matrix and collagen, and method for production of support matrix and composite
EP2968669B1 (de) Ultrafeine elektrogesponnene fasern aus poly-4-hydroxybutyrat und copolymere davon
Bini et al. Electrospun poly (L-lactide-co-glycolide) biodegradable polymer nanofibre tubes for peripheral nerve regeneration
Subramanian et al. Fabrication of uniaxially aligned 3D electrospun scaffolds for neural regeneration
EP3375461B1 (de) Gewebereparaturfasermembran, herstellungsverfahren und anwendung davon sowie gewebereparaturprodukt
AU772047B2 (en) Multi-channel bioresorbable nerve regeneration conduit and process for preparing the same
CN109876186B (zh) 一种用于神经修复的生物医用可降解双层支架及其制备方法
US20100047310A1 (en) Bio-acceptable conduits and method providing the same
EP1454641A2 (de) Mit Säugerzellen besiedelter implantierbarer poröser medizinischer Artikel
US20060095137A1 (en) Nanofibrous nonwoven membrane of silk fibroin for guided bone tissue regeneration and manufacturing method thereof
US20160175487A1 (en) Tissue repair scaffold and preparation method and purpose thereof
CN111000661B (zh) 一种复合型人造血管及其制备方法
KR101816286B1 (ko) 생분해성 고분자 나노 파이버의 배열이 서로 다른 내막과 외막이 연속적으로 연결된 다중막 구조의 튜브형 다공성 스캐폴드 및 이의 제조방법.
CN211583664U (zh) 一种复合型人造血管
KR101088656B1 (ko) 엘라스틴 성형체 및 그 제조법
JP4383763B2 (ja) 細胞培養基材およびその製造方法
JP4729293B2 (ja) 人工心臓弁、再生医療用基材及びその製造方法
Yen Nguyen et al. A review of current advances in biomaterials for neural tissue regeneration
TW200423976A (en) Anti-adhesive membrane and method for production thereof
Yucel et al. Nanotechnology in biomaterials: nanofibers in tissue engineering

Legal Events

Date Code Title Description
AS Assignment

Owner name: TEIJIN LIMITED, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KITAZONO, EIICHI;MIYOSHI, TAKANORI;KANEKO, HIROAKI;AND OTHERS;REEL/FRAME:017834/0687

Effective date: 20050922

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION